Latest bladder cancer Stories
Taiwanese author says his research should relieve concern among diabetics that insulin might raise their cancer risk. Raleigh, NC (PRWEB) February 19, 2014
University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Scientists find a “modest but clinically significant” link between the diabetes drug and bladder cancer. Raleigh, NC (PRWEB) February 17, 2014 The
Researchers say the diabetes drug does not appear to reduce the risk of bladder cancer in patients with type 2 diabetes. Raleigh, NC (PRWEB) February 14, 2014
National network of attorneys is providing consumer updates and no-cost consultations over allegations that the use of the diabetes medication Actos can cause patients to develop bladder cancer.
Study shows that in 95% of cases CellDetect(TM) distinguished staining and succeeded in identifying the cancerous cells TEL AVIV, Israel, Feb.
In the second whole-genome sequencing study ever conducted in bladder cancer, a Roswell Park-led team observed two distinct patterns of aberrations, and identified a potential target for therapy.
International studies demonstrate importance of comprehensive tumor profiling for poor-prognosis cancer patients IRVING, Texas, Jan.
Schlichter, Bogard & Denton, LLP is investigating and pursuing claims on behalf of individuals who allege that they have been diagnosed with bladder cancer after taking the diabetes medication
First Actos bellwether trial is underway, with the jury having been selected on Monday.
- A political dynamiter.